Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2015 1
2016 7
2017 6
2018 6
2019 3
2020 8
2021 8
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
Adebahr S, Althaus A, Scharl S, Strouthos I, Farolfi A, Serani F, Lanzafame H, Trapp C, Koerber SA, Peeken JC, Vogel MME, Vrachimis A, Spohn SKB, Grosu AL, Kroeze SGC, Guckenberger M, Fanti S, Hruby G, Emmett L, Belka C, Schmidt-Hegemann NS, Henkenberens C, Aebersold DM, Wiegel T, Afshar-Oromieh A, Zamboglou C, Shelan M. Adebahr S, et al. Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):558-567. doi: 10.1007/s00259-023-06438-3. Epub 2023 Sep 22. Eur J Nucl Med Mol Imaging. 2024. PMID: 37736808 Free PMC article.
Repeated SBRT for in- and out-of-field recurrences in the liver.
Gkika E, Strouthos I, Kirste S, Adebahr S, Schultheiss M, Bettinger D, Fritsch R, Brass V, Maruschke L, Neeff HP, Lang SA, Nestle U, Grosu AL, Brunner TB. Gkika E, et al. Among authors: adebahr s. Strahlenther Onkol. 2019 Mar;195(3):246-253. doi: 10.1007/s00066-018-1385-0. Epub 2018 Oct 23. Strahlenther Onkol. 2019. PMID: 30353350 English.
PSMA-PET- and MRI-Based Focal Dose Escalated Radiation Therapy of Primary Prostate Cancer: Planned Safety Analysis of a Nonrandomized 2-Armed Phase 2 Trial (ARO2020-01).
Zamboglou C, Spohn SKB, Ruf J, Benndorf M, Gainey M, Kamps M, Jilg C, Gratzke C, Adebahr S, Schmidtmayer-Zamboglou B, Mix M, Bamberg F, Zschaeck S, Ghadjar P, Baltas D, Grosu AL. Zamboglou C, et al. Among authors: adebahr s. Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):1025-1035. doi: 10.1016/j.ijrobp.2022.04.020. Epub 2022 Apr 22. Int J Radiat Oncol Biol Phys. 2022. PMID: 35469897 Free article. Clinical Trial.
Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters.
Marinescu IM, Rogg M, Spohn S, von Büren M, Kamps M, Jilg CA, Fountzila E, Papadopoulou K, Ceci L, Bettermann A, Ruf J, Benndorf M, Adebahr S, Zips D, Grosu AL, Schell C, Zamboglou C. Marinescu IM, et al. Among authors: adebahr s. Radiat Oncol. 2022 Oct 5;17(1):163. doi: 10.1186/s13014-022-02131-1. Radiat Oncol. 2022. PMID: 36199143 Free PMC article.
Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With De Novo Lymph Node-Positive Prostate Cancer.
Spohn SKB, Birkenmaier V, Ruf J, Mix M, Sigle A, Haehl E, Adebahr S, Sprave T, Gkika E, Rühle A, Nicolay NH, Kirste S, Grosu AL, Zamboglou C. Spohn SKB, et al. Among authors: adebahr s. Front Oncol. 2022 Jun 7;12:898774. doi: 10.3389/fonc.2022.898774. eCollection 2022. Front Oncol. 2022. PMID: 35747822 Free PMC article.
43 results